pityriasis%20(tinea)%20versicolor
PITYRIASIS (TINEA) VERSICOLOR
Pityriasis (Tinea) versicolor is a fungal infection caused by Malassezia furfur. It is benign, superficial, and localized to the stratum corneum.
It may present as chronic or recurrent infection and may occur in healthy individuals.
It is more common in summer than winter months.
It presents with multiple well-demarcated macules or patches and finely scaled plaques with hypopigmentation or hyperpigmentation, hence the term "versicolor".
Lesions are usually found on the upper trunk, chest, back and shoulders, and may extend toward the neck, face and arms.

Pharmacotherapy

  • Treatment is usually effective but may have to be repeated due to recurrence of infection in susceptible individuals
    • Prophylactic treatment is recommended for patients at risk of recurrence on exposure to sunlight or warm humid conditions
  • Skin discoloration may take several weeks to resolve after complete treatment
    • If mycology is negative, persisting pale patches do not necessarily warrant additional treatment
  • Topical agents can be very effective & are safer than systemic medications, especially in children

Topical Antifungals

  • Used as initial treatment
  • Desirable properties: High efficacy, favorable adverse effects profile, fewest possible daily applications, shortest duration of therapy, low relapse rate & cost-effectiveness

Selenium sulfide & Zinc pyrithione

  • Proven to be effective & safe; inexpensive for 1st-line therapy
  • May be used as maintenance regimen (apply on the 1st and 3rd day of each month and leave on for 5 min before rinsing)

Imidazoles

  • Highly effective, safe & fairly inexpensive

Combined steroid/imidazole agents

  • High-potency steroid combination is not indicated for treating Pityriasis (tinea) versicolor due to the absence of significant inflammation in this condition & the potential of the steroid component to induce atrophy

Oral Antifungals

  • Indicated in cases of severe or widespread skin involvement, recurrent infections, & failure of topical therapy

Initial Therapy

  • May use Selenium sulfide or Ketoconazole shampoo
  • Antifungal cream is advised for small areas of skin involvement
    • Imidazole creams may be used in both children & adults
  • If initial therapy fails, confirm adherence to treatment
    • May consider repeat topical treatment before starting systemic therapy

Systemic Therapy

  • Oral antifungal agents Itraconazole & Fluconazole are preferred

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Nov 2017
Fluarex Tetra - Inactivated quadrivalent influenza vaccine (split virion) vaccine (inj) 0.5 mL - GlaxoSmithKline
02 Nov 2017
In this issue of MIMS Anti-Infective Supplement, we bring you clinical updates related to combating infectious diseases, and also a symposium highlight in conjunction with the launch of ceftolozane/tazobactam (Zerbaxa; Merck Sharp & Dohme Sdn Bhd) in Malaysia. 
30 Oct 2016
Close to a quarter of the world’s population (1.7 billion) were latently infected with Mycobacterium tuberculosis (M.tb) in 2014, according to estimates using mathematical modelling.
10 Sep 2016
More men than women are diagnosed with tuberculosis (TB) in low- and middle-income countries, according to a study. Furthermore, men are also less likely to get access to TB care in many settings.